Why Your Reflux Isn’t Healing Even on PPIs
Why It Matters
Because PPIs alone often fail to resolve LPR, incorporating barrier techniques can restore voice function and prevent long‑term tissue damage, reshaping standard reflux management.
Key Takeaways
- •Pepsin persists in tissue despite acid suppression by PPIs.
- •LPR involves reflux reaching laryngeal tissue, causing voice loss.
- •PPIs don’t stop reflux movement; barrier strategies are essential.
- •Diaphragmatic breathing and alginate create physical reflux barriers.
- •Reducing dietary acidity limits pepsin activation during healing.
Summary
Patients with laryngopharyngeal reflux (LPR) often remain symptomatic despite two years on proton‑pump inhibitors (PPIs). The video explains that while PPIs can lower stomach acid, they do not prevent refluxate from reaching the laryngeal tissue, where the enzyme pepsin continues to cause damage and voice loss.
Research shows pepsin can embed in mucosal cells and reactivate whenever the local pH falls below six. Because PPIs only suppress acid production, they leave the underlying mechanism—upward movement of reflux—untreated. Consequently, patients may experience ongoing inflammation even with “controlled” reflux on medication.
The presenter recommends barrier‑focused strategies: strengthening the lower esophageal sphincter through diaphragmatic breathing after meals, and using an alginate suspension to form a protective coat in the esophagus. Reducing acidic foods further limits pepsin activation, creating a true healing environment.
Adopting these measures shifts treatment from acid suppression to reflux prevention, offering relief for voice professionals and anyone with chronic LPR. It underscores the need for clinicians to address reflux mechanics, not just gastric acidity.
Comments
Want to join the conversation?
Loading comments...